The first Theriva Biologics trade was made in Q4 2018.
Since then Ken Griffin bought shares four more times and sold shares on three occasions. The investor sold all their shares in Q1 2022 and doesn't own any shares in Theriva Biologics anymore.
Avg closing price
Price range
Sold -27.8 Thousand shares
Q1 2022
Avg closing price
$2.73
Price range
$2.30
-
$4.30
Increased shares by 536.2% (+23.4 Thousand shares)
Q4 2021
Avg closing price
$3.77
Price range
$2.72
-
$4.54
Increased shares by 313.0% (+3.31 Thousand shares)
Q3 2021
Avg closing price
$4.98
Price range
$4.31
-
$5.78
Sold 98.0% shares (-52.9 Thousand shares)
Q2 2021
Avg closing price
$5.73
Price range
$4.60
-
$7.20
New holding (+53.9 Thousand shares)
Q1 2021
Avg closing price
$7.90
Price range
$5.00
-
$11.70
Sold -2.55 Thousand shares
Q2 2019
Avg closing price
$5.76
Price range
$4.91
-
$6.60
Increased shares by 85.1% (+1.17 Thousand shares)
Q1 2019